SLC5A2 and anemia (phenotype): On the other hand, almost all patients with nephrotic range proteinuria had no increase in hemoglobin with SGLT2 inhibitor treatment in this study, suggesting that the expected anemia-improving effect of SGLT2 inhibitors may not be observed depending on the severity of albuminuria.